| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 2960 | 2023 |
| Saroglitazar, a PPAR‐α/γ agonist, for treatment of NAFLD: a randomized controlled double‐blind phase 2 trial S Gawrieh, M Noureddin, N Loo, R Mohseni, V Awasty, K Cusi, ... Hepatology 74 (4), 1809-1824, 2021 | 289 | 2021 |
| Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage MS Siddiqui, G Yamada, R Vuppalanchi, M Van Natta, R Loomba, C Guy, ... Clinical gastroenterology and hepatology 17 (9), 1877-1885. e5, 2019 | 263 | 2019 |
| Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort SA Harrison, S Gawrieh, K Roberts, CJ Lisanti, RB Schwope, KM Cebe, ... Journal of hepatology 75 (2), 284-291, 2021 | 227 | 2021 |
| High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population E Vilar‐Gomez, LD Nephew, R Vuppalanchi, S Gawrieh, A Mladenovic, ... Hepatology 75 (6), 1491-1506, 2022 | 199 | 2022 |
| Vitamin E improves transplant‐free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis E Vilar‐Gomez, R Vuppalanchi, S Gawrieh, M Ghabril, R Saxena, ... Hepatology 71 (2), 495-509, 2020 | 183 | 2020 |
| Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease M Charlton, P Angulo, N Chalasani, R Merriman, K Viker, ... Hepatology 47 (2), 484-492, 2008 | 148 | 2008 |
| Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children KP Newton, HS Feldman, CD Chambers, L Wilson, C Behling, JM Clark, ... The Journal of pediatrics 187, 141-146. e1, 2017 | 119 | 2017 |
| Automatic classification of white regions in liver biopsies by supervised machine learning S Vanderbeck, J Bockhorst, R Komorowski, DE Kleiner, S Gawrieh Human pathology 45 (4), 785-792, 2014 | 115 | 2014 |
| Effects of interventions on intra-and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology S Gawrieh, DM Knoedler, K Saeian, JR Wallace, RA Komorowski Annals of diagnostic pathology 15 (1), 19-24, 2011 | 108 | 2011 |
| Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study S Gawrieh, L Dakhoul, E Miller, A Scanga, A DeLemos, C Kettler, ... Alimentary pharmacology & therapeutics 50 (7), 809-821, 2019 | 105 | 2019 |
| High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation M Venu, E Martin, K Saeian, S Gawrieh Liver Transplantation 19 (6), 627-633, 2013 | 93 | 2013 |
| Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study DQ Huang, LA Wilson, C Behling, DE Kleiner, KV Kowdley, S Dasarathy, ... Gastroenterology 165 (2), 463-472. e5, 2023 | 90 | 2023 |
| Histologic findings of advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease who have normal aminotransferase levels S Gawrieh, LA Wilson, OW Cummings, JM Clark, R Loomba, B Hameed, ... Official journal of the American College of Gastroenterology| ACG 114 (10 …, 2019 | 90 | 2019 |
| Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis JD Yang, MF Abdelmalek, CD Guy, RM Gill, JE Lavine, K Yates, J Klair, ... Clinical Gastroenterology and Hepatology 15 (1), 127-131. e2, 2017 | 89 | 2017 |
| Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation S Gawrieh, BG Papouchado, LJ Burgart, S Kobayashi, MR Charlton, ... Liver transplantation 11 (10), 1207-1213, 2005 | 87 | 2005 |
| Long‐term metformin use may improve clinical outcomes in diabetic patients with non‐alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis E Vilar‐Gomez, R Vuppalanchi, AP Desai, S Gawrieh, M Ghabril, ... Alimentary Pharmacology & Therapeutics 50 (3), 317-328, 2019 | 78 | 2019 |
| Primate fetal hepatic responses to maternal obesity: epigenetic signalling pathways and lipid accumulation S Puppala, C Li, JP Glenn, R Saxena, S Gawrieh, A Quinn, J Palarczyk, ... The Journal of physiology 596 (23), 5823-5837, 2018 | 72 | 2018 |
| Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis B Hameed, NA Terrault, RM Gill, R Loomba, N Chalasani, JH Hoofnagle, ... Alimentary pharmacology & therapeutics 47 (5), 645-656, 2018 | 72 | 2018 |
| A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients A Ulitsky, AN Ananthakrishnan, R Komorowski, J Wallace, SN Surapaneni, ... Obesity surgery 20, 685-691, 2010 | 69 | 2010 |
